<?xml version="1.0" encoding="UTF-8"?>
<ref id="bph15207-bib-0087">
 <mixed-citation publication-type="journal" id="bph15207-cit-0088">
  <string-name>
   <surname>Zhang</surname>, 
   <given-names>W.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhao</surname>, 
   <given-names>Y.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhang</surname>, 
   <given-names>F.</given-names>
  </string-name>, 
  <string-name>
   <surname>Wang</surname>, 
   <given-names>Q.</given-names>
  </string-name>, 
  <string-name>
   <surname>Li</surname>, 
   <given-names>T.</given-names>
  </string-name>, 
  <string-name>
   <surname>Liu</surname>, 
   <given-names>Z.</given-names>
  </string-name>, … 
  <string-name>
   <surname>Zhang</surname>, 
   <given-names>S.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>The use of anti‐inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID‐19): The perspectives of clinical immunologists from China</article-title>. 
  <source xml:lang="en">Clinical Immunology</source>, 
  <volume>214</volume>, 
  <fpage>108393</fpage>
  <pub-id pub-id-type="doi">10.1016/j.clim.2020.108393</pub-id>
  <pub-id pub-id-type="pmid">32222466</pub-id>
 </mixed-citation>
</ref>
